Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2016

01-08-2016 | Original Article

The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis

Authors: Ming Hui, Xiaojuan Yan, Ying Jiang

Published in: Clinical and Experimental Medicine | Issue 3/2016

Login to get access

Abstract

Many studies have reported the association between tumor necrosis factor-α (TNF-α)-238 polymorphism and digestive system cancer susceptibility, but the results were inconclusive. We performed a meta-analysis to derive a more precise estimation of the relationship between TNF-α-238 G/A polymorphism and digestive system cancer risk. Pooled analysis for the TNF-α-238 G/A polymorphism contained 26 studies with a total of 4849 cases and 8567 controls. The meta-analysis observed a significant association between TNF-α-238 G/A polymorphism and digestive system cancer risk in the overall population (GA vs GG: OR 1.19, 95 % CI 1.00–1.40, P heterpgeneity = 0.016; A vs G: OR 1.19, 95 % CI 1.03–1.39, P heterpgeneity = 0.015; dominant model: OR 1.20, 95 % CI 1.02–1.41, P heterpgeneity = 0.012). In the analysis of the ethnic subgroups, however, similar results were observed only in the Asian population, but not in the Caucasian population. Therefore, this meta-analysis suggests that TNF-α-238 G/A polymorphism is associated with a significantly increased risk of digestive system cancer. Further large and well-designed studies are needed to confirm these findings.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference Burn J, Mathers J, Bishop DT. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res. 2013;191:157–83.CrossRefPubMed Burn J, Mathers J, Bishop DT. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res. 2013;191:157–83.CrossRefPubMed
3.
go back to reference Pellegrini ML, Argibay P, Gomez DE. Genetics and epigenetics of colorectal cancer. Acta Gastroenterol Latinoam. 2011;41(3):247–61.PubMed Pellegrini ML, Argibay P, Gomez DE. Genetics and epigenetics of colorectal cancer. Acta Gastroenterol Latinoam. 2011;41(3):247–61.PubMed
4.
go back to reference Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012;10(1):18.CrossRefPubMedPubMedCentral Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012;10(1):18.CrossRefPubMedPubMedCentral
7.
go back to reference Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248:171–83.CrossRefPubMed Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248:171–83.CrossRefPubMed
8.
9.
go back to reference Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.CrossRefPubMed Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.CrossRefPubMed
10.
go back to reference Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1:3–19.CrossRefPubMed Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1:3–19.CrossRefPubMed
11.
go back to reference Gupta R, Sharma SC, Das SN. Association of TNF-α and TNFR1 promoters and 30 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol. 2008;44:455–63.CrossRefPubMed Gupta R, Sharma SC, Das SN. Association of TNF-α and TNFR1 promoters and 30 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol. 2008;44:455–63.CrossRefPubMed
12.
go back to reference Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008;118:1395–9.CrossRefPubMed Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008;118:1395–9.CrossRefPubMed
13.
go back to reference Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180–3.CrossRefPubMed Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180–3.CrossRefPubMed
14.
go back to reference Govan VA, Constant D, Hoffman M, et al. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphismin South African women with cervical cancer and control women. BMC Cancer. 2006;6:24.CrossRefPubMedPubMedCentral Govan VA, Constant D, Hoffman M, et al. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphismin South African women with cervical cancer and control women. BMC Cancer. 2006;6:24.CrossRefPubMedPubMedCentral
15.
go back to reference Nakajima K, Sasaki M, Nojima D, et al. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol. 2001;165:612–5.CrossRefPubMed Nakajima K, Sasaki M, Nojima D, et al. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol. 2001;165:612–5.CrossRefPubMed
16.
go back to reference Marsh HP, Haldar NA, Bunce M, et al. Polymorphisms in tumor necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumor at presentation. Br J Cancer. 2003;89:1096–101.CrossRefPubMedPubMedCentral Marsh HP, Haldar NA, Bunce M, et al. Polymorphisms in tumor necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumor at presentation. Br J Cancer. 2003;89:1096–101.CrossRefPubMedPubMedCentral
17.
go back to reference Mestiri S, Bouaouina N, Ahmed SB, et al. Genetic variation in the tumor necrosis factoralpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer. 2001;91:672–8.CrossRefPubMed Mestiri S, Bouaouina N, Ahmed SB, et al. Genetic variation in the tumor necrosis factoralpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer. 2001;91:672–8.CrossRefPubMed
18.
go back to reference Shih CM, Lee YL, Chiou HL, et al. Association of TNFalpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.CrossRefPubMed Shih CM, Lee YL, Chiou HL, et al. Association of TNFalpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.CrossRefPubMed
19.
go back to reference Jung KW, Ha E, Yu GI, et al. TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407:16–9.CrossRefPubMed Jung KW, Ha E, Yu GI, et al. TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407:16–9.CrossRefPubMed
20.
go back to reference Chen X, Zhang L, Chang Y, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a Han Chinese population. Int J Biol Markers. 2011;26:181–7.CrossRefPubMed Chen X, Zhang L, Chang Y, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a Han Chinese population. Int J Biol Markers. 2011;26:181–7.CrossRefPubMed
21.
go back to reference Jeng JE, Tsai HR, Chuang LY, et al. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore). 2009;88:349–57.CrossRef Jeng JE, Tsai HR, Chuang LY, et al. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore). 2009;88:349–57.CrossRef
22.
go back to reference Jang WH, Yang YI, Yea SS, et al. The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41–6.CrossRefPubMed Jang WH, Yang YI, Yea SS, et al. The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41–6.CrossRefPubMed
23.
go back to reference Crusius JB, Canzian F, Capella G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894–902.CrossRefPubMed Crusius JB, Canzian F, Capella G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894–902.CrossRefPubMed
24.
go back to reference Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104:617–23.CrossRefPubMed Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104:617–23.CrossRefPubMed
25.
go back to reference Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol. 2008;103:407–15.CrossRefPubMed Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol. 2008;103:407–15.CrossRefPubMed
26.
go back to reference Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139:73–83.CrossRefPubMed Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139:73–83.CrossRefPubMed
27.
go back to reference Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.CrossRefPubMed Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.CrossRefPubMed
28.
go back to reference Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4:e5360.CrossRefPubMedPubMedCentral Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4:e5360.CrossRefPubMedPubMedCentral
29.
30.
go back to reference Shih CM, Lee YL, Chiou HL, et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.CrossRefPubMed Shih CM, Lee YL, Chiou HL, et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.CrossRefPubMed
31.
go back to reference Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–6.CrossRefPubMed Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–6.CrossRefPubMed
32.
go back to reference Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141–52.CrossRefPubMed Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141–52.CrossRefPubMed
33.
go back to reference Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammationrelated genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–25.CrossRefPubMed Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammationrelated genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–25.CrossRefPubMed
34.
go back to reference Yu JY, Li L, Ma H, Liu K, Cheng X, Li YL, Song XL. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumor Biol. 2013;34(6):3859–63.CrossRef Yu JY, Li L, Ma H, Liu K, Cheng X, Li YL, Song XL. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumor Biol. 2013;34(6):3859–63.CrossRef
Metadata
Title
The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis
Authors
Ming Hui
Xiaojuan Yan
Ying Jiang
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 3/2016
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0363-4

Other articles of this Issue 3/2016

Clinical and Experimental Medicine 3/2016 Go to the issue